Alzheimer's disease and its treatment by different approaches: A review
Alzheimer's disease (AD) is a neurodegenerative disorder that impairs mental ability
development and interrupts neurocognitive function. This neuropathological condition is …
development and interrupts neurocognitive function. This neuropathological condition is …
[HTML][HTML] Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer's disease: Current trends and future perspectives
Alzheimer's disease (AD), the most common form of dementia, is a progressive and
multifactorial neurodegenerative disorder whose primary causes are mostly unknown. Due …
multifactorial neurodegenerative disorder whose primary causes are mostly unknown. Due …
Nanomedicine for the treatment of Alzheimer's disease
Alzheimer's disease affects more than 35 million people worldwide and this number is
presumed to double by the year 2050. Currently, there is no efficient therapy for this disorder …
presumed to double by the year 2050. Currently, there is no efficient therapy for this disorder …
Overcoming the blood–brain barrier: the role of nanomaterials in treating neurological diseases
Therapies directed toward the central nervous system remain difficult to translate into
improved clinical outcomes. This is largely due to the blood–brain barrier (BBB), arguably …
improved clinical outcomes. This is largely due to the blood–brain barrier (BBB), arguably …
[HTML][HTML] Recent advances in the treatment of Alzheimer's disease using nanoparticle-based drug delivery systems
P Poudel, S Park - Pharmaceutics, 2022 - mdpi.com
Alzheimer's disease (AD) is an irreversible and progressive neurodegenerative disorder.
Most existing treatments only provide symptomatic solutions. Here, we introduce currently …
Most existing treatments only provide symptomatic solutions. Here, we introduce currently …
Micro-and nanotechnology approaches to improve Parkinson's disease therapy
PV Torres-Ortega, L Saludas, AS Hanafy… - Journal of controlled …, 2019 - Elsevier
Current therapies for Parkinson's disease are symptomatic and unable to regenerate the
brain tissue. In recent years, the therapeutic potential of a wide variety of neuroprotective …
brain tissue. In recent years, the therapeutic potential of a wide variety of neuroprotective …
[HTML][HTML] Recent advancements of nanoparticles application in cancer and neurodegenerative disorders: At a glance
Nanoscale engineering is one of the innovative approaches to heal multitudes of ailments,
such as varieties of malignancies, neurological problems, and infectious illnesses …
such as varieties of malignancies, neurological problems, and infectious illnesses …
Nanoparticle formulations in the diagnosis and therapy of Alzheimer's disease
Alzheimer's disease (AD) is one of the most common age-related diseases that occurs
because of the deposition of amyloid fibrils in a form of extracellular plaques containing β …
because of the deposition of amyloid fibrils in a form of extracellular plaques containing β …
A review on advances of treatment modalities for Alzheimer's disease
Alzheimer's disease (AD) is a multifactorial neurodegenerative disease which is mainly
characterized by progressive impairment in cognition, emotion, language and memory in …
characterized by progressive impairment in cognition, emotion, language and memory in …
Nanotechnology based theranostic approaches in Alzheimer's disease management: current status and future perspective
Background: Alzheimer's disease (AD), a cognitive dysfunction/dementia state amongst the
elders is characterized by irreversible neurodegeneration due to varied pathophysiology. Up …
elders is characterized by irreversible neurodegeneration due to varied pathophysiology. Up …